RVMD
Revolution Medicines, Inc.NASDAQHealthcare$99.12+0.49%ClosedMarket Cap: $19.64B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
11.55
P/S
0.00
EV/EBITDA
-17.10
DCF Value
$0.87
FCF Yield
-4.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-63.1%
ROA
-49.5%
ROIC
-56.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-361.6M | $-364.9M | $-1.90 | — |
| FY 2025 | $0.00 | -Infinity% | $-1.18B | $-1.13B | $-5.95 | — |
| Q3 2025 | $0.00 | NaN% | $-315.3M | $-305.2M | $-1.61 | — |
| Q2 2025 | $0.00 | NaN% | $-264.7M | $-247.8M | $-1.31 | — |
| Q1 2025 | $0.00 | NaN% | $-240.8M | $-213.4M | $-1.13 | — |
| Q4 2024 | $0.00 | NaN% | $-216.3M | $-194.6M | $-1.13 | — |
| FY 2024 | $0.00 | NaN% | $-689.5M | $-600.1M | $-3.58 | — |
| Q3 2024 | $0.00 | NaN% | $-175.7M | $-156.3M | $-0.94 | — |
| Q2 2024 | $0.00 | NaN% | $-156.6M | $-133.2M | $-0.81 | — |
| Q1 2024 | $0.00 | NaN% | $-140.9M | $-116.0M | $-0.70 | — |
| Q4 2023 | $742.0K | 100.0% | $-180.0M | $-161.5M | $-1.14 | — |
| FY 2023 | $11.6M | 100.0% | $-487.2M | $-436.4M | $-3.86 | — |